All molecular changes (3784)
Identifier
Name
Gene
Data
Tissues
Organism
Actions
DAA135
malate dehydrogenase 1, NAD (soluble)
MDH1
4.0% Decrease Gene Expression Level
brain
Human
DAA424
malate dehydrogenase 1, NAD (soluble)
MDH1
3.0% Decrease Gene Expression Level
skeletal muscle
Human
DAA298
malate dehydrogenase 2, NAD (mitochondrial)
MDH2
2.0% Decrease Gene Expression Level
skeletal muscle
Human
DAA409
malectin
MLEC
4.0% Decrease Gene Expression Level
skeletal muscle
Human
DAA1790
male-specific lethal 2 homolog (Drosophila)
Msl2
3.0% Increase Gene Expression Level
muscle
Mouse
DAA431
malic enzyme 2, NAD(+)-dependent, mitochondrial
ME2
5.0% Decrease Gene Expression Level
skeletal muscle
Human
DAA136
malic enzyme 3, NADP(+)-dependent, mitochondrial
ME3
5.0% Decrease Gene Expression Level
brain
Human
DAA1310
MAM domain containing 2
Mamdc2
7.0% Decrease Gene Expression Level
hematological system
Mouse
DAA351
mannan-binding lectin serine peptidase 2
MASP2
3.0% Increase Gene Expression Level
skeletal muscle
Human
DAA1511
mannose-binding lectin (protein C) 2
Mbl2
4.0% Increase Gene Expression Level
liver
Mouse
DAA1416
mannose-P-dolichol utilization defect 1
Mpdu1
3.0% Increase Gene Expression Level
hippocampus
Mouse
DAA1651
mannosyl-oligosaccharide glucosidase
Mogs
5.0% Decrease Gene Expression Level
lung
Mouse
DAA1267
MAS-related GPR, member A4
Mrgpra4
92.0% Decrease Gene Expression Level
brain
Mouse
DAA1474
matrix Gla protein
Mgp
12.0% Increase Gene Expression Level
kidney
Mouse
DAA1526
matrix metallopeptidase 14 (membrane-inserted)
Mmp14
5.0% Increase Gene Expression Level
liver
Mouse
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
MMP7
23.0% Increase Gene Expression Level
kidney
Human
DAA1636
Max interacting protein 1
Mxi1
4.0% Increase Gene Expression Level
lung
Mouse
DAA1504
mechanistic target of rapamycin (serine/threonine kinase)
Mtor
3.0% Decrease Gene Expression Level
kidney
Mouse
DAA86
mechanistic target of rapamycin (serine/threonine kinase)
MTOR
7.0% Decrease Gene Expression Level
brain
Human
DAA139
megalencephalic leukoencephalopathy with subcortical cysts 1
MLC1
10.0% Increase Gene Expression Level
brain
Human
DAA1358
Meis homeobox 2
Meis2
17.0% Increase Gene Expression Level
hematological system
Mouse
DAA394
melanoma antigen family D, 2
MAGED2
3.0% Increase Gene Expression Level
skeletal muscle
Human
DAA1870
melanoma antigen, family D, 2
Maged2
2.0% Increase Gene Expression Level
skeletal muscle
Mouse
DAA1660
membrane-associated ring finger (C3HC4) 7
March7
4.0% Increase Gene Expression Level
lung
Mouse
DAA1786
membrane-associated ring finger (C3HC4) 7
March7
4.0% Increase Gene Expression Level
muscle
Mouse
| Identifier | Name | Gene | Data | Tissues | Organism | Actions |
|---|---|---|---|---|---|---|
| DAA135 | malate dehydrogenase 1, NAD (soluble) | MDH1 | 4.0% Decrease Gene Expression Level | brain | Human | |
| DAA424 | malate dehydrogenase 1, NAD (soluble) | MDH1 | 3.0% Decrease Gene Expression Level | skeletal muscle | Human | |
| DAA298 | malate dehydrogenase 2, NAD (mitochondrial) | MDH2 | 2.0% Decrease Gene Expression Level | skeletal muscle | Human | |
| DAA409 | malectin | MLEC | 4.0% Decrease Gene Expression Level | skeletal muscle | Human | |
| DAA1790 | male-specific lethal 2 homolog (Drosophila) | Msl2 | 3.0% Increase Gene Expression Level | muscle | Mouse | |
| DAA431 | malic enzyme 2, NAD(+)-dependent, mitochondrial | ME2 | 5.0% Decrease Gene Expression Level | skeletal muscle | Human | |
| DAA136 | malic enzyme 3, NADP(+)-dependent, mitochondrial | ME3 | 5.0% Decrease Gene Expression Level | brain | Human | |
| DAA1310 | MAM domain containing 2 | Mamdc2 | 7.0% Decrease Gene Expression Level | hematological system | Mouse | |
| DAA351 | mannan-binding lectin serine peptidase 2 | MASP2 | 3.0% Increase Gene Expression Level | skeletal muscle | Human | |
| DAA1511 | mannose-binding lectin (protein C) 2 | Mbl2 | 4.0% Increase Gene Expression Level | liver | Mouse | |
| DAA1416 | mannose-P-dolichol utilization defect 1 | Mpdu1 | 3.0% Increase Gene Expression Level | hippocampus | Mouse | |
| DAA1651 | mannosyl-oligosaccharide glucosidase | Mogs | 5.0% Decrease Gene Expression Level | lung | Mouse | |
| DAA1267 | MAS-related GPR, member A4 | Mrgpra4 | 92.0% Decrease Gene Expression Level | brain | Mouse | |
| DAA1474 | matrix Gla protein | Mgp | 12.0% Increase Gene Expression Level | kidney | Mouse | |
| DAA1526 | matrix metallopeptidase 14 (membrane-inserted) | Mmp14 | 5.0% Increase Gene Expression Level | liver | Mouse | |
| DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | MMP7 | 23.0% Increase Gene Expression Level | kidney | Human | |
| DAA1636 | Max interacting protein 1 | Mxi1 | 4.0% Increase Gene Expression Level | lung | Mouse | |
| DAA1504 | mechanistic target of rapamycin (serine/threonine kinase) | Mtor | 3.0% Decrease Gene Expression Level | kidney | Mouse | |
| DAA86 | mechanistic target of rapamycin (serine/threonine kinase) | MTOR | 7.0% Decrease Gene Expression Level | brain | Human | |
| DAA139 | megalencephalic leukoencephalopathy with subcortical cysts 1 | MLC1 | 10.0% Increase Gene Expression Level | brain | Human | |
| DAA1358 | Meis homeobox 2 | Meis2 | 17.0% Increase Gene Expression Level | hematological system | Mouse | |
| DAA394 | melanoma antigen family D, 2 | MAGED2 | 3.0% Increase Gene Expression Level | skeletal muscle | Human | |
| DAA1870 | melanoma antigen, family D, 2 | Maged2 | 2.0% Increase Gene Expression Level | skeletal muscle | Mouse | |
| DAA1660 | membrane-associated ring finger (C3HC4) 7 | March7 | 4.0% Increase Gene Expression Level | lung | Mouse | |
| DAA1786 | membrane-associated ring finger (C3HC4) 7 | March7 | 4.0% Increase Gene Expression Level | muscle | Mouse |